Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Current Deferred Revenue (2020 - 2025)

Trulieve Cannabis (TCNNF) has 6 years of Current Deferred Revenue data on record, last reported at $9.6 million in Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 19.49% year-over-year to $9.6 million; the TTM value through Dec 2025 reached $9.6 million, up 19.49%, while the annual FY2025 figure was $9.6 million, 19.49% up from the prior year.
  • Current Deferred Revenue reached $9.6 million in Q4 2025 per TCNNF's latest filing, up from $8.9 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $9.6 million in Q4 2025 and bottomed at $1.3 million in Q4 2023.
  • Average Current Deferred Revenue over 5 years is $6.3 million, with a median of $6.7 million recorded in 2024.
  • Peak YoY movement for Current Deferred Revenue: tumbled 85.89% in 2023, then soared 501.35% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $6.7 million in 2021, then surged by 41.18% to $9.5 million in 2022, then crashed by 85.89% to $1.3 million in 2023, then skyrocketed by 501.35% to $8.0 million in 2024, then increased by 19.49% to $9.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $9.6 million in Q4 2025, $8.9 million in Q3 2025, and $8.4 million in Q2 2025.